Dr. Alex Morgan brings a broad analytical perspective to biotechnology, healthcare innovation, and life sciences strategy. With experience spanning research, industry analysis, and market intelligence, Alex examines how scientific progress, capital flows, and policy decisions intersect. At BioIntel, Alex focuses on connecting developments across domains to surface the strategic implications that matter most to industry leaders.